Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 98.52% | 0.00% | -11.44% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -66.67% | 0.00% | 285.45% | 0.00% |
| Total Amortization of Deferred Charges | 0.00% | -- | -- | -- | 0.00% |
| Total Other Non-Cash Items | 0.00% | -224.84% | 0.00% | -21.98% | 0.00% |
| Change in Net Operating Assets | 0.00% | -- | -- | -- | 0.00% |
| Cash from Operations | 0.00% | -67.28% | 0.00% | 125.31% | 0.00% |
| Capital Expenditure | 0.00% | -1,164.52% | 0.00% | -416.67% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -1,164.52% | 0.00% | -416.67% | 0.00% |
| Total Debt Issued | 0.00% | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -136.50% | 0.00% | -1.38% | 0.00% |
| Issuance of Common Stock | 0.00% | 1,730.71% | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 3,191.76% | 0.00% | 188.39% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | -2,309.09% | 0.00% | 178.57% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 1,097.98% | 0.00% | 129.03% | 0.00% |